Fundz

Immune Xcite, Inc. reported raising $5.76 Million in an initial SEC Form D filing, from an offering of $6.77 Million

PRIVATEDec 10, 2015$5.8M of $6.8M raised

Amount Raised

$5.76 Million

$5.76 Million sold, per SEC Form D (first sale Dec 10, 2015)

Round Type

Venture

LexingtonBiotechnology

Quick answer

ImmuneXcite, Inc. raised $5.76 Million in a funding round, dated December 10, 2015. ImmuneXcite, Inc. is based in Lexington, Massachusetts, United States.

How much did ImmuneXcite, Inc. raise?
ImmuneXcite, Inc. raised $5.76 Million in a funding round on December 10, 2015.
What does ImmuneXcite, Inc. do?
ImmuneXcite offers a platform technology for enhancing the efficacy of therapeutic monoclonal antibodies for disease targets.
Where is ImmuneXcite, Inc. based and how big is it?
ImmuneXcite, Inc. is based in Lexington, Massachusetts, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as ImmuneXcite, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • USBC raised $66K (Pre-Seed) on January 22, 2016.
  • Adaptive Sensory Technology, Inc. raised $1M (Seed) on January 22, 2016.
  • Pivot Bio raised $8.1M on January 22, 2016.
  • Cancer Prevention Pharmaceuticals, Inc. raised $5M on January 22, 2016.
  • MiMedx raised $4M (Seed) on January 22, 2016.
  • Peptilogics raised $417K (Seed) on January 21, 2016.

Who to call at ImmuneXcite, Inc., and when

A new round usually means ImmuneXcite, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day ImmuneXcite, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ImmuneXcite, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ImmuneXcite, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ImmuneXcite, Inc.

Location

3 Forbes Road

Lexington, Massachusetts, United States

About

ImmuneXcite offers a platform technology for enhancing the efficacy of therapeutic monoclonal antibodies for disease targets.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ImmuneXcite, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for ImmuneXcite, Inc.'s next move

See what Strategic adds

ImmuneXcite, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.